A GREAT HOPE “vaccine against diabetes”

A GREAT HOPE “vaccine against diabetes”

BBC MUNDO © Derechos Reservados 

In humans vaccine against diabetes 

The vaccine consists in the inoculation of a protein that protects the insulin-producing cells and slows their destruction. 

EFE.-A vaccine to prevent type 1 diabetes, which is at the same time a treatment to slow down its evolution, will begin in August to be tested in humans in the United Kingdom. 

Georgina Slack, director of diabetes research in the UK, told the British newspaper “The Times” that the project is very promising and commented that “a hundred years ago, type 1 diabetics were sentenced to die, however, today they are they are making great strides to cure the disease. “

The vaccine, developed by researchers at the University of Bristol and King’s College London, involves the inoculation of a protein that protects insulin-producing cells (pancreatic beta cells) and slows their destruction. 

Eighteen patients, already selected, will be inoculated with the vaccine to study their reaction, although they will not be given a complete treatment. 

Type 1 diabetes is an autoimmune disease that affects 1.5 percent of the world’s population and usually develops in childhood or adolescence. 

People who suffer from it have to inject synthetic insulin every day to control their blood sugar levels because they destroy the cells that secrete it.

Colin Dayan, one of those responsible for the study at the University of Bristol, said that if the treatment, which has already been successfully tested in mice, “works (in humans), we will do a full eighteen-month test, and if there are no problems we will work on a more complex vaccine “. 

“If it is possible to stop the evolution of the disease in already diagnosed patients and keep them in that situation, it will be one of the greatest achievements of history,” Dayan said. 

The research will also provide very useful data for the treatment of patients who suffer severe cases of type 2 diabetes, typical of the obese, in which the body does not respond normally to insulin itself or does not produce enough.

Clinalfa, subsidiary of the pharmaceutical giant Merck, is in charge of producing the vaccine ..

Spread the love